{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:45:22Z","timestamp":1785912322715,"version":"3.56.0"},"reference-count":79,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["acrjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Arthritis Care &amp;amp; Research"],"abstract":"<jats:p>Spondyloarthritis (SpA) is a group of chronic inflammatory diseases encompassing axial and peripheral forms, with up to 20% of patients developing symptoms before age 16. Despite this substantial pediatric burden, treatment options for juvenile\u2010onset SpA (JSpA), particularly those with axial disease (axJSpA), remain limited. This gap underscores the need for evidence\u2010based approaches to extend effective therapies to children. This review highlights the strong parallels between adult axial SpA (axSpA) and axJSpA, supporting the appropriateness of extrapolating efficacy and target drug exposure data from adults to children. Adult\u2010 and axJSpA share key clinical and pathogenic features, including overlapping clinical symptoms, genetic susceptibility, and treatment approaches. Classification systems also align: adult axSpA is classified according to the Assessment of Spondyloarthritis International Society criteria, whereas children are classified using the recently validated axJSpA criteria, which closely mirrors the adult framework. Treatment paradigms further reinforce these similarities. Nonsteroidal anti\u2010inflammatory drugs and tumor necrosis factor inhibitors are standard therapy in both adults and children, and emerging mechanisms, such as inhibition of interleukin\u201017A\/F and JAK, are relevant across age groups. However, the absence of approved agents for axJSpA underscores the importance of leveraging data from adults. Given the shared biology, clinical phenotype, treatment response patterns, and the availability of shared outcome measures such as the Spondyloarthritis Research Consortium of Canada magnetic resonance imaging inflammation and structural scores, extrapolating efficacy and target drug exposure data from adults with axSpA to children with axJSpA is scientifically justified and critical for addressing the unmet therapeutic needs in affected youth.<\/jats:p>","DOI":"10.1002\/acr.80111","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:32:41Z","timestamp":1783330361000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From Adult to Adolescent: Alignment in Clinical Trials and Outcomes in Axial Spondyloarthritis"],"prefix":"10.1002","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9724-0443","authenticated-orcid":false,"given":"Pamela F.","family":"Weiss","sequence":"first","affiliation":[{"name":"University of Pennsylvania and Children's Hospital of Philadelphia  Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4158-8253","authenticated-orcid":false,"given":"Judith A.","family":"Smith","sequence":"additional","affiliation":[{"name":"University of Wisconsin School of Medicine and Public Health University of Wisconsin\u2010Madison  Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6237-4575","authenticated-orcid":false,"given":"Robert A.","family":"Colbert","sequence":"additional","affiliation":[{"name":"National Institute of Arthritis, Musculoskeletal, and Skin Diseases, NIH  Bethesda Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3858-7065","authenticated-orcid":false,"given":"Erin","family":"Treemarcki","sequence":"additional","affiliation":[{"name":"University of Utah and Primary Children's Hospital  Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5568-388X","authenticated-orcid":false,"given":"Michael H.","family":"Weisman","sequence":"additional","affiliation":[{"name":"Stanford University  Palo Alto California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1291-1755","authenticated-orcid":false,"given":"Walter P.","family":"Maksymowych","sequence":"additional","affiliation":[{"name":"University of Alberta and CARE Arthritis  Edmonton Alberta Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9478-2987","authenticated-orcid":false,"given":"Hermine I.","family":"Brunner","sequence":"additional","affiliation":[{"name":"University of Cincinnati, Cincinnati Children's Hospital Medical Center  Cincinnati Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Childhood Arthritis and Rheumatology Research Alliance, Spondyloarthritis Research and Treatment Network, and Pediatric Rheumatology Collaborative Study Group Advisory Council","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2021.07.001"},{"issue":"2","key":"e_1_2_4_3_1","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty RE","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_4_4_1","volume-title":"Addendum to ICH E11: Clinical Investigation of Medicinal Products in the Pediatric Population E11(R1)","author":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use","year":"2017"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42959"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-022-00533-y"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-025-00725-2"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24529"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.108233"},{"issue":"11","key":"e_1_2_4_10_1","article-title":"The Assessments in Spondyloarthritis International Society (ASAS) and Spondyloarthritis Research and Treatment Network (SPARTAN) revised classification criteria for axial spondyloarthritis: development and validation in the classification of Axial SpA Inception Cohort Study","volume":"77","author":"Maksymowych W","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-10-14"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22885"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25491"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01387-x"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1406182"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001450"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780401015"},{"key":"e_1_2_4_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202520617"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/594878"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.680916"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/msc.1694"},{"key":"e_1_2_4_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3235"},{"issue":"3","key":"e_1_2_4_23_1","first-page":"498","article-title":"HLA\u2010B*27\/HLA\u2010B*07 in combination with D6S273\u2010134 allele is associated with increased susceptibility to juvenile spondyloarthropathies","volume":"26","author":"Harjacek M","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2005.09.004"},{"key":"e_1_2_4_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203352"},{"key":"e_1_2_4_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12880"},{"issue":"2","key":"e_1_2_4_27_1","first-page":"337","article-title":"IL\u201027 levels are low in enthesitis\u2010related arthritis category of juvenile idiopathic arthritis","volume":"34","author":"Gaur P","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.081179"},{"issue":"3","key":"e_1_2_4_29_1","first-page":"515","article-title":"Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases","volume":"35","author":"Agarwal S","year":"2008","journal-title":"J Rheumatol"},{"key":"e_1_2_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2015.07.012"},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115416"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq362"},{"key":"e_1_2_4_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket375"},{"issue":"10","key":"e_1_2_4_34_1","first-page":"1542","article-title":"Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study","volume":"18","author":"Mielants H","year":"1991","journal-title":"J Rheumatol"},{"key":"e_1_2_4_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205253"},{"key":"e_1_2_4_36_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110508"},{"key":"e_1_2_4_37_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.650619"},{"key":"e_1_2_4_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1510-6"},{"key":"e_1_2_4_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22024"},{"issue":"7","key":"e_1_2_4_40_1","first-page":"1349","article-title":"Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis","volume":"32","author":"Saxena N","year":"2005","journal-title":"J Rheumatol"},{"key":"e_1_2_4_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38318"},{"key":"e_1_2_4_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.4.263"},{"key":"e_1_2_4_43_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.681621"},{"key":"e_1_2_4_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222849"},{"key":"e_1_2_4_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25465"},{"key":"e_1_2_4_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23870"},{"key":"e_1_2_4_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24025"},{"key":"e_1_2_4_48_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14093166"},{"key":"e_1_2_4_49_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-002165"},{"key":"e_1_2_4_50_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.221022"},{"key":"e_1_2_4_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-024-01323-9"},{"key":"e_1_2_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(22)00185-0"},{"key":"e_1_2_4_53_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2023-0015"},{"key":"e_1_2_4_54_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-023-03128-1"},{"key":"e_1_2_4_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41911"},{"key":"e_1_2_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32534-6"},{"key":"e_1_2_4_57_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202245"},{"key":"e_1_2_4_58_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201766"},{"key":"e_1_2_4_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22657"},{"key":"e_1_2_4_60_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4072"},{"key":"e_1_2_4_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39805"},{"key":"e_1_2_4_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-018-0238-9"},{"key":"e_1_2_4_63_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2022-222747"},{"key":"e_1_2_4_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2021.07.021"},{"key":"e_1_2_4_65_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.181088"},{"key":"e_1_2_4_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25565"},{"key":"e_1_2_4_67_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202976"},{"key":"e_1_2_4_68_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.2.127"},{"key":"e_1_2_4_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04662-w"},{"key":"e_1_2_4_70_1","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-10-S1-A45"},{"key":"e_1_2_4_71_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120131"},{"key":"e_1_2_4_72_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02157-4"},{"key":"e_1_2_4_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1543-x"},{"key":"e_1_2_4_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000914"},{"issue":"12","key":"e_1_2_4_75_1","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index","volume":"21","author":"Calin A","year":"1994","journal-title":"J Rheumatol"},{"key":"e_1_2_4_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.10.012"},{"key":"e_1_2_4_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22627"},{"key":"e_1_2_4_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22411"},{"key":"e_1_2_4_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24516"},{"issue":"12","key":"e_1_2_4_80_1","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett S","year":"1994","journal-title":"J Rheumatol"}],"container-title":["Arthritis Care &amp; Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acr.80111","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/acr.80111","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acr.80111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:52:59Z","timestamp":1785909179000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/acr.80111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":79,"alternative-id":["10.1002\/acr.80111"],"URL":"https:\/\/doi.org\/10.1002\/acr.80111","archive":["Portico"],"relation":{},"ISSN":["2151-464X","2151-4658"],"issn-type":[{"value":"2151-464X","type":"print"},{"value":"2151-4658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"2026-02-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"acr.80111"}}